Home Tags Pharmaceuticals
The world’s biggest fund managers are dumping tech to an extent not seen since the financial crisis — here’s what they’re scoo...
Investors are the least optimistic on tech stocks since the depths of the financial crisis, and are instead piling into a safer area — healthcare.
Evidence is mounting that psychedelic drugs can help treat diseases. Here are the most promising uses
There's been a resurgence of interest in psychedelic drugs' potential to treat conditions like depression. Research is beginning to lead to new treatments.
A drug derived from marijuana has triggered the first federal shift on cannabis in half a century, and experts predict an avalanche effect
The nation's top drug regulator has officially changed how it regulates FDA-approved drugs that contain CBD, a marijuana compound, with the approval of the epilepsy drug Epidiolex. It's the first time in 46 years that the Drug Enforcement Administration has shifted its stance on cannabis.
A startup with ties to Bayer has inked a $122 million deal to make lab-grown marijuana — and it’s eyeing the pharma industry
Boston-based startup Ginkgo Bioworks will use Cronos' labs to produce synthetic marijuana compounds, many of which "have the potential to be valuable in a range of pharmaceutical applications."
Stanford researchers are figuring out how ketamine fights depression — and why the drug has been called ‘the most important discovery in h...
A new Stanford study is the first to illuminate how ketamine works in the brain to alleviate depression. The research suggests that the drug engages the opioid system — the same one that's activated by opioid painkillers — in addition to affecting the glutamate system.
The strange history of the EpiPen, the device developed by the military that turned into a billion-dollar business and now faces generic competition b...
Here's the story of how a common, lifesaving device became a controversial drug-pricing story, facing recalls, shortages, and now generic competition between Mylan and Teva.
The drug maker behind the first FDA-approved medication derived from marijuana has revealed how much it’ll cost
On a call with investors this week, GW Pharmaceuticals revealed the price of Epidiolex, its newly-approved, marijuana-based drug for rare forms of epilepsy.
DNA-testing company 23andMe has signed a $300 million deal with a drug giant. Here’s how to delete your data if that freaks you out.
Genetics-testing companies like Ancestry and 23andMe can — and frequently do — sell your data to drugmakers. A $300 million deal between 23andMe and the pharmaceutical giant GlaxoSmithKline is the latest example. If that has you thinking about how these companies use your data, here's how to delete it.
Doctors are calling out a new drug that helps people with addiction for costing more than $1,700 a week — while a generic costs just $1
Two months after it became the first federally approved drug of its kind to treat addiction, doctors are calling out Lucemyra, a new branded medication to treat opioid withdrawal, for costing $1,737 more per week than a similar generic drug.
A pharma CEO says a new depression drug could have lasting effects after one short course, like antibiotics — here’s what experts think
Sage Therapeutics CEO Jeff Jonas said the new drug could help depressed people feel well "with just a two week course of treatment — similar to how antibiotics are used." No existing drug works that way, and this one hasn't yet been studied beyond a limited time frame when most drugs fail.